Drug Profile
Research programme: Alzheimer's disease therapeutics - Clera
Alternative Names: CLR 097Latest Information Update: 28 Feb 2018
Price :
$50
*
At a glance
- Originator Clera
- Class
- Mechanism of Action Amyloid beta-protein inhibitors; Amyloid beta-protein precursor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 28 Feb 2018 No recent reports of development identified for research development in Alzheimer's-disease in Canada
- 01 Jan 2014 Early research in Alzheimer's disease in Canada (unspecified route)